EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studies

J. Antonio Aviña‐Zubieta, Hyon K. Choi, Mohsen Sadatsafavi, Mahyar Etminan, John M. Esdaile, Diane Lacaille

Arthritis Care & Research · 2008-12-15 · 59 (12) · 1690-1697

DOI: 10.1002/art.24092 ↗
AbstractBibliografische Angaben

Abstract

Abstract Objective To determine the magnitude of risk of cardiovascular mortality in patients with rheumatoid arthritis (RA) compared with the general population through a meta‐analysis of observational studies. Methods We searched Medline, EMBase, and Lilacs databases from their inception to July 2005. Observational studies that met the following criteria were assessed by 2 researchers: 1) prespecified RA definition, 2) clearly defined cardiovascular disease (CVD) outcome, including ischemic heart disease (IHD) and cerebrovascular accidents (CVAs), and 3) reported standardized mortality ratios (SMRs) and 95% confidence intervals (95% CIs). We calculated weighted–pooled summary estimates of SMRs (meta‐SMRs) for CVD, IHD, and CVAs using the random‐effects model, and tested for heterogeneity using the I 2 statistic. Results Twenty‐four studies met the inclusion criteria, comprising 111,758 patients with 22,927 cardiovascular events. Overall, there was a 50% increased risk of CVD death in patients with RA (meta‐SMR 1.50, 95% CI 1.39–1.61). Mortality risks for IHD and CVA were increased by 59% and 52%, respectively (meta‐SMR 1.59, 95% CI 1.46–1.73 and meta‐SMR 1.52, 95% CI 1.40–1.67, respectively). We identified asymmetry in the funnel plot (Egger's test P = 0.002), as well as significant heterogeneity in all main analyses ( P < 0.0001). Subgroup analyses showed that inception cohort studies (n = 4, comprising 2,175 RA cases) were the only group that did not show a significantly increased risk for CVD (meta‐SMR 1.19, 95% CI 0.86–1.68). Conclusion Published data indicate that CVD mortality is increased by ∼50% in RA patients compared with the general population. However, we found that study characteristics may influence the estimate.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →